Am J Transplant, Volume 18, Suppl 3 Archives - Page 195 of 211 - ATC Abstracts

2018 American Transplant Congress
When Does Donor Age Matter? A Review of over 70,000 Liver Transplants
D. Yoeli, E. Pan, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss, A. Rana.
Surgery, Baylor College of Medicine, Houston, TX.
Background: Past studies on donor age in liver transplantation have largely relied on binary groups (i.e., young vs. old) with arbitrarily defined cut-offs. The aim…
2018 American Transplant Congress
Utilization of Older Donor after Cardiac Death Allografts in Liver Transplantation: An Opportunity to Increase the Donor Pool
F. Paterno, K. Wima, T. Diwan, M. Cuffy, N. Anwar, E. Woodle, S. Shah.
Surgery, University of Cincinnati, Cincinnati, OH.
BackgroundDonors after cardiac death (DCD) liver allografts have been underutilized in liver transplantation especially in case of old donor age due to concerns of worse…
2018 American Transplant Congress
Graft and Patient Outcomes after Kidney Transplant for American Indians
R. Seipp, N. Zhang, H. Khamash, S. Leischow, A. Sharma, R. Heilman, M. Keddis.
Mayo Clinic, Phoenix.
Introduction: American Indian (AI) patients experience significant disparity in access to kidney transplant (KTx) with reported similar graft outcomes after KTx. Our objective is to…
2018 American Transplant Congress
Gender Disparities in Need for Dialysis, Access to the Renal Transplant Waitlist and Renal Transplant Survival
B. Schmidt,¹ J. Epping,² C. Falk,⁴ S. Geyer,² A. Melk.³
¹Nephrology and Hypertension, Hannover Medical School, Hannover, Germany; ²Medical Sociology, Hannover Medical School, Hannover, Germany; ³Pediatric Nephrology, Hannover Medical School, Hannover, Germany; ⁴Institute of Transplantation Immunology, Hannover Medical School, Hannover, Germany.
A patient with chronic kidney disease undergoes several transition phases, such as start of dialysis, the placement on the transplant waiting list and finally renal…
2018 American Transplant Congress
Pancreas Outcomes between Living and Deceased Kidney Donor Recipients in Pancreas after Kidney Transplantation
P. Ventura-Aguiar,¹ J. Ferrer,² I. Revuelta,¹ D. Paredes,³ E. De-Sousa,¹ J. Rovira,⁴ E. Esmatjes,⁵ J. Garcia-Valdecasas,² F. Oppenheimer,¹ F. Diekmann,¹ M. Ricart.¹
¹Nephrology and Kidney Transplantation Department, Hospital Clinic, Barcelona, Spain; ²Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic, Barcelona, Spain; ³Organ Transplantation Coordination Department, Hospital Clinic, Barcelona, Spain; ⁴Laboratori Experimental de Nefrologia I Trasplantament (LENIT), IDIBAPS, Barcelona, Spain; ⁵Diabetes Unit, Department of Endocrinology and Nutrition, Hospital Clinic, Barcelona, Spain.
Pancreas outcomes in pancreas after kidney transplantation have been reported as being inferior to those from simultaneous pancreas-pancreas (SPK). The influence of kidney donor (living-…
2018 American Transplant Congress
Estimation of Beta Cell Function after Total Pancreatectomy with Islet Autotransplantation Using Single Fasting Blood Sample Based Indices and Modified Igls Score.
J. Gołębiewska,¹ P. Bachul,² L. Basto,² M. Kijek,² N. Fillman,² K. Cieply,² K. Golab,² L. Wang,² M. Tibudan,² C. Thomas,³ A. Dębska-Ślizień,¹ J. Fung,² P. Witkowski.²
¹Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland; ²Surgery, University of Chicago, Chicago; ³Medicine, University of Chicago, Chicago.
Background: For precise yet logistically feasible evaluation of beta-cell function after total pancreatectomy with islet autotransplantation (TPIAT), we investigated the utility of indices using only…
2018 American Transplant Congress
Virtual Encounters: Robust Methods to Manage Your Active Waitlist
K. Curry, S. Zimmerman, D. Cassidy, S. Gray, V. Rao, V. Rohan, N. Pilch, A. Milling, L. Curry.
Transplant, MUSC, Charleston, SC.
Introduction: The ability to ensure all patients are transplant ready and do not have outstanding issues that would diminish post-transplant outcomes is challenging with an…
2018 American Transplant Congress
The Providers Can't Let Go! An Analysis of an RN Driven Tacrolimus Dose Adjustment Protocol
Z. Elmaasarani, C. Mardis, L. Gylten, J. Fleming, H. Meadows, N. Patel, C. Perez, D. Taber, V. Rao, V. Rohan, P. Baliga, D. Dubay, N. Pilch.
MUSC, Charleston.
Introduction: Tacrolimus (FK) dose adjustment is frequently performed by non-MD staff. Standard protocols to evaluate the ability of non-providers to maintain pts within a goal…
2018 American Transplant Congress
Myeloid Derived Suppressor Cells Are Induced after Transplantation and Home to the Transplanted Kidney
Y. Lee, E. Davila, J. Bromberg, J. Scalea.
Surgery and Immunology, University of Maryland, Baltimore, MD.
BACKGROUND: Myeloid-derived suppressor cells (MDSCs) are a naturally occurring, heterogeneous population of highly immunosuppressive cells which expand in response to inflammatory conditions such as cancer.…
2018 American Transplant Congress
Renal Allograft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation
L. Gallon,¹ J. Mathew,¹ S. Bontha,² C. Dumur,² P. Dalal,¹ L. Nadimpalli,¹ D. Maluf,² A. Shetty,¹ S. Ildstad,³ J. Leventhal,¹ V. Mas.²
¹Department of Medicine-Nephrology, Northwestern University, Chicago, IL; ²Department of Surgery, University of Virginia, Charlottesville, VA; ³Departments of Surgery, Physiology and Immunology, University of Louisville, Louisville, KY.
Background: Chronic exposure to immunosuppressive agents for organ transplant results in graft nephrotoxicity, infections and malignancies We have established durable immune tolerance in mismatched related…